These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6863985)

  • 1. Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro.
    Woo TY; Hogan VA; Patel H; Anhalt GJ; Labib RS; Voorhees JJ; Diaz LA
    J Invest Dermatol; 1983 Jul; 81(1 Suppl):115s-21s. PubMed ID: 6863985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells.
    Kawana S; Geoghegan WD; Jordon RE
    Clin Exp Immunol; 1985 Sep; 61(3):517-25. PubMed ID: 3907901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization.
    Patel HP; Diaz LA; Anhalt GJ; Labib RS; Takahashi Y
    J Invest Dermatol; 1984 Dec; 83(6):409-15. PubMed ID: 6389716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement.
    Kawana S; Geoghegan WD; Jordon RE
    J Invest Dermatol; 1986 Jan; 86(1):29-33. PubMed ID: 3745932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes.
    Takahashi Y; Patel HP; Labib RS; Diaz LA; Anhalt GJ
    J Invest Dermatol; 1985 Jan; 84(1):41-6. PubMed ID: 3965577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigoid and pemphigus antigens in cultured epidermal cells.
    Diaz LA; Marcelo CL
    Br J Dermatol; 1978 Jun; 98(6):631-7. PubMed ID: 354682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
    Anhalt GJ; Patel HP; Labib RS; Diaz LA; Proud D
    J Immunol; 1986 Jan; 136(1):113-7. PubMed ID: 3079604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase.
    Farb RM; Dykes R; Lazarus GS
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):459-63. PubMed ID: 272663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen.
    Doubleday CW; Geoghegan WD; Jordon RE
    J Lab Clin Med; 1988 Jan; 111(1):28-34. PubMed ID: 3335823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus vulgaris autoimmune globulin induces Src-dependent tyrosine-phosphorylation of plakophilin 3 and its detachment from desmoglein 3.
    Cirillo N; AlShwaimi E; McCullough M; Prime SS
    Autoimmunity; 2014 Mar; 47(2):134-40. PubMed ID: 24328683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation.
    Hashimoto K; Shafran KM; Webber PS; Lazarus GS; Singer KH
    J Exp Med; 1983 Jan; 157(1):259-72. PubMed ID: 6681540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The desmosome and hemidesmosome in cutaneous autoimmunity.
    Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the role of complement in experimental pemphigus vulgaris in mice.
    Anhalt GJ; Till GO; Diaz LA; Labib RS; Patel HP; Eaglstein NF
    J Immunol; 1986 Nov; 137(9):2835-40. PubMed ID: 3760574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
    Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
    Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
    Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
    Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated rosette formation of epidermal cells with leukocytes in pemphigus vulgaris.
    Katayama I; Hashimoto K; Nishioka K
    Arch Dermatol Res; 1985; 278(2):87-91. PubMed ID: 4096544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Ashkenazi L; Milner Y; Frusic-Zlotkin M; Anhalt GJ; David M; Shoenfeld Y
    Clin Exp Immunol; 2005 Dec; 142(3):426-32. PubMed ID: 16297153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of p38MAPK signalling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis.
    Egu DT; Walter E; Spindler V; Waschke J
    Br J Dermatol; 2017 Dec; 177(6):1612-1618. PubMed ID: 28600798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus.
    Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA
    Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells.
    Aoyama Y; Kitajima Y
    J Invest Dermatol; 1999 Jan; 112(1):67-71. PubMed ID: 9886266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.